ArticleMultiple sclerosis journal - experimental, translational and clinical
Differences in disease burden between neuromyelitis optica spectrum disorder and multiple sclerosis in South China.
Article in Multiple sclerosis journal - experimental, translational and clinical. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) differ substantially in pathophysiological mechanisms, clinical manifestations and therapeutic management. Objectives: To investigate the disease burden of NMOSD and MS in South China and analyse the differences in disease burden between the two. Methods: We extracted the demographic characteristics, diagnoses, duration of hospitalization and mortality from the direct reporting system of health information. Results: From 2016 to 2022, the study identified 12,799 hospital admissions for 8204 patients with NMOSD and 6783 hospital admissions for 5125 patients with MS. The female-to-male ratio among patients with MS was 1.82. The peak age of NMOSD diagnosis was 45-55 years. The peak age of MS diagnosis was 25-35 years. The average duration of hospitalization for patients with NMOSD was 12 (7-17) days, whereas that for patients with MS was 10 (6-14) days. The percentage of NMOSD admissions to the intensive care unit was higher than that of MS admissions. The mortality rate for both NMOSD and MS was 0.2%. Conclusions: In South China, the disease burden of NMOSD is heavier than that of MS. The NMOSD exhibited a higher number of cases, longer duration of hospitalization and more severe clinical conditions than MS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.